No, but this one seems to be. Please, you tell me why it keeps hitting new lows. I don’t know.
I watched wild market gyrations when I owned and followed IMCL before they were bought out, but an effective cancer drug is more likely to have a steady market than this “we are better than Botox” company has so far.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.